Johnson & Johnson (JNJ) Stock Price, Quote, News & History | Benzinga

Johnson & Johnson (JNJ) Stock Price, Quote, News & History

JNJNYSE

Trade with Public

Trade with Public

$230.69

-3.49-1.49%

At close: Apr 20, 5:00 PM EST

$231.43

0.740.32%

After Hours: 7:57 PM EST

Earnings: Q1 2026 Earnings were released on Tue Apr 14th, before the market open

Conference Call: The most recent conference call started at 8:30 AM, 6 days ago

Click to view the webcast

M&A: Johnson & Johnson (JNJ) announced it will sell assets to MeiraGTx Holdings (MGTX) on Thursday, April 16, 2026

OverviewNews Earnings Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$234.81

Close

$230.69

Volume / Avg.

7.81M / 8.63M

Day Range

$229.53 - $235.26

52 Wk Range

146.12 - 251.71

Market Cap

$557.73B

P/E Ratio

21.23

Dividend Yield

2.29%

Exchange

NYSE

RSI

35

Short Interest

0.92%

Days to Cover

2.76

Recent Johnson & Johnson News

Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson

MeiraGTx reacquires bota-vec from Johnson & Johnson, outlining regulatory plans, funding outlook, and updated xerostomia data.

Vandana Singh

These Analysts Boost Their Forecasts On Johnson & Johnson Following Strong Q1 Results

Johnson & Johnson (NYSE:JNJ) reports upbeat earnings for Q1, with higher sales and raised fiscal 2026 guidance. Some analysts raise price targets.

Avi Kapoor

Johnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish Analyst

Johnson & Johnson reports strong Q1, beating expectations and setting the stage for future growth. Analysts maintain Buy rating.

Priya Nigam

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

24.53B

Investing Cash Flow (TTM)

-23.59B

Financing Cash Flow (TTM)

-5.54B

Free Cash Flow (TTM)

19.31B

Capital Expenditure (TTM)

-5.22B

Net Change in Cash (TTM)

-4.60B

Analyst Trends and Forecast

5

3

Jan

1

Feb

3

2

Mar

3

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$591.88B

PE Ratio (TTM)

21.23

PE Ratio (FWD)

20.28

PEG Ratio (TTM)

3.05

PS Ratio (TTM)

6.04

PB Ratio (TTM)

6.92

Earnings Yield % (TTM)

4.71%

Earnings Yield % (FWD)

4.93%

EV / EBITDA (TTM)

14.42

Price / EBITDA (TTM)

13.86

Price / Free Cash Flow (TTM)

29.46

Book Value / Share

$33.86

Company Debt

Total Debt

$47.93B

LT Debt

$39.44B

LT Debt Issuance (TTM)

$9.14B

LT Debt Repayment (TTM)

-$1.76B

Total Cash

$19.71B

Debt to Equity

0.59

Issuance of Debt (TTM)

$7.38B

Repayment of Debt (TTM)

-$14.09B

Key Statistics

Open

$234.81

Close

$230.69

Volume / Avg.

7.81M / 8.63M

Day Range

$229.53 - $235.26

52 Wk Range

146.12 - 251.71

Market Cap

$557.73B

P/E Ratio

21.23

Dividend Yield

2.29%

Exchange

NYSE

RSI

35

Short Interest

0.92%

Days to Cover

2.76

About

Sector

Health Care

Industry

Pharmaceuticals

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Johnson & Johnson (JNJ) stock?

A

You can purchase shares of Johnson & Johnson (NYSE:JNJ) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Johnson & Johnson (JNJ) competitors?

A

Other companies in Johnson & Johnson’s space includes: Novo Nordisk AS (NYSE:NVO), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS), Terns Pharmaceuticals Inc (NASDAQ:TERN) and Haleon PLC (NYSE:HLN).

Q

What is the forecast, or price target, for Johnson & Johnson (JNJ) stock?

A

Johnson & Johnson has a consensus price target of $234.30.

Q

What is the current price for Johnson & Johnson (JNJ)?

A

The stock price for Johnson & Johnson (NYSE: JNJ) is $231.4331 last updated April 20, 2026 at 7:57 PM EDT.

Q

Does Johnson & Johnson (JNJ) pay a dividend?

A

There are no upcoming dividends for Johnson & Johnson.

Q

When is Johnson & Johnson (NYSE:JNJ) reporting earnings?

A

Johnson & Johnson does not have any upcoming earnings scheduled.

Q

Is Johnson & Johnson (JNJ) going to split?

A

There is no upcoming split for Johnson & Johnson.

Q

What sector and industry does Johnson & Johnson (JNJ) operate in?

A

Johnson & Johnson is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

People Also Watch

Novo Nordisk AS

Terns Pharmaceuticals Inc

Axsome Therapeutics Inc

Ligand Pharmaceuticals Inc